MED Naproxen - ATI medications sheet PDF

Title MED Naproxen - ATI medications sheet
Author Kira Fullerton
Course Medical Pharmacology
Institution Missouri State University
Pages 1
File Size 58.7 KB
File Type PDF
Total Downloads 67
Total Views 126

Summary

ATI medications sheet...


Description

ACTIVE LEARNING TEMPLATE:

Medication

Fullerton STUDENT NAME Kira _____________________________________ MEDICATION Naproxen __________________________________________________________________________

REVIEW MODULE CHAPTER ___________

CATEGORY CLASS ______________________________________________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action Inhibits prostaglandin synthesis.

Therapeutic Use Decreased pain. Reduction of fever. Suppression of inflammation.

Complications dizziness, drowsiness, headache, HF, MYOCARDIAL INFARCTION, STROKE, edema, hypertension, palpitations, tachycardia

Medication Administration Delayed-release tablets (EC-Naprosyn): 375 mg, 500 mg Extended-release tablets: 750 mg Canadian Tradename Oral suspension (Naprosyn): 125 mg/5 mL Rectal suppositories : 500 mg Canadian Tradename Tablets (Naprosyn): 125 mg Canadian Tradename, 250 mg, 375 mg, 500 mg In Combination with: esomeprazole (Vimovo). Naproxen Sodium Capsules (Maxidol): 220 mgOTC Canadian Tradename Extended-release tablets (Naprelan): 375 mg, 500 mg, 750 mg Tablets (Aleve, Anaprox, Anaprox DS): 220 mgOTC, 275 mg, 550 mg

Contraindications/Precautions Hypersensitivity; Cross-sensitivity may occur with other NSAIDs, including aspirin; Active GI bleeding; Ulcer disease; Coronary artery bypass graft (CABG) surgery;

Interactions May limit the cardioprotective (antiplatelet) effects of aspirin. Additive adverse GI side effects with aspirin, corticosteroids, alcohol, and other NSAIDs.

Nursing Interventions Monitor BP during initiation and periodically during therapy. May cause fluid retention and edema leading to new onset or worsening hypertension. Monitor temperature; note signs associated with fever

Client Education Evaluation of Medication Effectiveness Relief of pain. Improved joint mobility. Partial arthritic relief is usually seen within 2 wk, but maximum effectiveness may require 2– 4 wk of continuous therapy. Patients who do not respond to one NSAID may respond to another. Reduction of fever.

ACTIVE LEARNING TEMPLATES

Instruct patient to take medication as directed. Take missed doses as soon as remembered but not if almost time for the next dose. Do not double doses. Advise patient to take this medication with a full glass of water and to remain in an upright position for 15– 30 min after administration. May cause drowsiness or dizziness. Advise patient to avoid driving or other activities requiring alertness until response to the medication is known.

THERAPEUTIC PROCEDURE

A7...


Similar Free PDFs